Carole Ho - Concepedia

Author

Carole Ho

Stanford University

Also Known As

Carole Ho

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Stanford University Howard Hughes Medical Institute University of California, Irvine

About

Carole Ho is an author at Stanford University specializing in medicine, cell biology, and neuroregeneration.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	950
2	Cell Biology	2	2	534
3	Health Sciences	1	1	93
4	Social Sciences	1	1	157
5	Cellular Physiology	1	1	124

Carole Ho

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Lack of Enhanced Spinal Regeneration in Nogo-Deficient Mice Binhai Zheng, Carole Ho, Shuxin Li, Neuron Regenerative MedicineNeuroregenerationSpinal Cord InjuryEnhanced Spinal RegenerationNeural Tissue Engineering	2003	377
Genetic deletion of the Nogo receptor does not reduce neurite inhibition <i>in vitro</i> or promote corticospinal tract regeneration <i>in vivo</i> Binhai Zheng, Jasvinder K. Atwal, Carole Ho, Proceedings of the National Academy of Sciences	2005	271
Targeting factor D of the alternative complement pathway reduces geographic atrophy progression secondary to age-related macular degeneration Brian L. Yaspan, David F. Williams, Frank G. Holz, Science Translational Medicine Complement SystemOcular DiseaseOphthalmologyFactor DAge-related Diseases	2017	178
Axotomy-Induced Smad1 Activation Promotes Axonal Growth in Adult Sensory Neurons Hongyan Zou, Carole Ho, Karen Wong, Journal of Neuroscience NeuroregenerationDevelopmental BiologyMolecular NeurosciencePeripheral BranchNeuroanatomy	2009	157
A Role for Nogo Receptor in Macrophage Clearance from Injured Peripheral Nerve Elizabeth J. Fry, Carole Ho, Samuel David Neuron InflammationMolecular PhysiologyPeripheral Nerve InjuryMedicinePhysiology	2007	124
The dorsolateral corticospinal tract in mice: An alternative route for corticospinal input to caudal segments following dorsal column lesions Oswald Steward, Binhai Zheng, Carole Ho, The Journal of Comparative Neurology Dlcst AxonsMotor ControlSpinal DisorderExperimental NeuropathologyNeurology	2004	93
O4‐11‐06: A RANDOMIZED, DOUBLE‐BLIND, PLACEBO‐CONTROLLED PHASE 2 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF CRENEZUMAB IN PATIENTS WITH MILD TO MODERATE ALZHEIMER'S DISEASE Jeffrey L. Cummings, Michael E. Ward, Michel Friesenhahn, Alzheimer s & Dementia Neurodegenerative DiseasesScreening Mmse ScoreAlzheimer's DiseasePlacebo‐controlled Phase 2Pharmacology	2014	21

Page 1